stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G/A - AN2 Therapeutics, Inc. | StockGist | StockGist
Companies
ANTX
SCHEDULE 13G/A
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
ANTX
SCHEDULE 13G/A
SCHEDULE 13G/A
Beneficial Ownership
Amendment
AN2 Therapeutics, Inc.
Filed Feb 13, 2026
Accepted Feb 12, 2026, 7:00 PM ET
ANTX
CIK 0001880438
View on SEC.gov
Company Profile
0001193125-26-051535
Beneficial Ownership Report
Passive Investment
Shares Owned
27,402,024
Reporting Person
AN2 Therapeutics, Inc.
Person Type
IN
CUSIP: 037326105
Amendment History
2 filings
SCHEDULE 13G
Original
Mar 13, 2026
0001104659-26-027730
SCHEDULE 13G/A
Amendment 1
Latest
Viewing
Feb 13, 2026
0001193125-26-051535